IRADIMED CORPORATION (IRMD) Operating cash flow 2016–2025
IRADIMED CORPORATION (IRMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$24.9MFY2025 · since FY2016: $9.4M → $24.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.9M | -2.6% |
| FY2024 | $25.6M | +90.3% |
| FY2023 | $13.5M | +34.1% |
| FY2022 | $10.0M | -10.8% |
| FY2021 | $11.3M | +93.5% |
| FY2020 | $5.8M | -43.1% |
| FY2019 | $10.2M | +38.7% |
| FY2018 | $7.4M | +115.9% |
| FY2017 | $3.4M | -63.7% |
| FY2016 | $9.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IRMD financial trends
IRMD RevenueIRMD Net incomeIRMD Net marginIRMD Gross profitIRMD Gross marginIRMD Operating incomeIRMD Operating marginIRMD Free cash flowIRMD Capital expendituresIRMD Return on equityIRMD Stock buybacksIRMD Dividends paidIRMD Total assetsIRMD Total liabilitiesIRMD Shareholders’ equityIRMD overview →